InvestorsHub Logo
Followers 10
Posts 1040
Boards Moderated 0
Alias Born 07/08/2006

Re: BostonTrader post# 275659

Monday, 10/30/2017 10:26:20 PM

Monday, October 30, 2017 10:26:20 PM

Post# of 402482
Would this not apply to a lot of other R&D entities and not just Elite? Nasrat has a business plan and I am willing, as a long investor, to see how this plays out. My money. . . to lose or to appreciate in value. I need no counselling on when to buy or sell.

What will be said if they aren't or they don't make a lot of money



I suppose people (traders?) are moving their money into other plays. Do you not think they will return when the ANDA approvals become a reality? As far as I am concerned the great news, that you speak of, is yet to come. You know. . .the FDA warning letter resolution and ANDA approvals.

Why would people be selling so much given all this great news? Makes zero sense unless there is something you are missing

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News